echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > Stroke: Stroke, residual inflammatory factors themselves, can effectively predict recurrence of stroke

    Stroke: Stroke, residual inflammatory factors themselves, can effectively predict recurrence of stroke

    • Last Update: 2021-09-03
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

     

    For stroke patients, although low-density lipoprotein cholesterol (LDL-C) is currently clinically actively reduced , patients still have recurrent vascular events
    .

    Cholesterol blood vessel

    Inflammation may be an important factor in causing this residual risk
    .

    Early clinical trials have proven the effectiveness of primary prevention against residual inflammatory risk (RIR)
    .

    prevention

    In addition, a recent study showed that anti-inflammatory treatments have a protective effect on cardiovascular disease, but have no effect on low-density lipoprotein cholesterol levels
    .

    Cardiovascular

    As a determinant of RIR, high-sensitivity C-reactive protein (hsCRP) is considered to be at least as important as LDL-C and is a determinant of residual cholesterol risk (RCR)
    .


    Early identification of high-risk patients and timely activation of secondary prevention is the most important


    Stroke

    In this way, Jiejie Li and others of Tiantan Hospital used the Third China National Stroke Registry (CNSR-III), a prospective multicenter cohort study: a total of 10,499 consecutive acute ischemic strokes and transient brains were included.
    Patients with ischemic attack, and tested the levels of LDL-C and hsCRP
    .

    Using the Third China National Stroke Registry (CNSR-III), this prospective multicenter cohort study: a total of 10,499 consecutive acute ischemic stroke and transient ischemic attack patients were included, and LDL-C was tested And the level of hsCRP
    .


    Patients were divided into 4 groups: residual cholesterol risk only (LDL-C≥2.
    6 mmol/L and hsCRP <3 mg/L), residual inflammation risk (RIR) only (LDL-C <2.
    6 mmol/L and hsCRP≥3 mg /L), both risks are present (LDL-C≥2.
    6 mmol/L and hsCRP≥3 mg/L), and neither risk (LDL-C <2.
    6 mmol/L and hsCRP<3 mg/L)
    .

    Main outcome: Stroke recurrence and a modified Rankin scale score of 2 to 6 within 1 year
    .

    They found that the relative proportions of patients with only RIR, only residual cholesterol risk, two risks, and neither of them were 21.
    3%, 23.
    7%, 14.
    4%, and 40.
    6%, respectively
    .

    Only RIR was independently associated with recurrent stroke (adjusted hazard ratio, 1.
    18 [95% CI, 1.
    00-1.
    40]; P=0.
    05)
    .

    Only RIR was independently associated with recurrent stroke (adjusted hazard ratio, 1.
    18 [95% CI, 1.
    00-1.
    40]; P=0.
    05)
    .


    In addition to traditional risk factors, after further adjusting the use of antiplatelet drugs and statins during the 1-year follow-up period, this association weakened slightly (HR=1.
    31 [95% CI, 0.
    99-1.
    76]; P=0.
    07)
    .


    When the LDL-C cutoff value of 1.


    Patients with only RIR also have an increased risk of adverse functional outcomes (HR=1.
    43 [95% CI, 1.
    24-1.
    64]; P<0.
    0001)
    .

    The significance of this study is to find that in patients with acute ischemic stroke or transient ischemic attack, only RIR can predict recurrent stroke, especially those with large atherosclerosis, and adverse functional outcomes
    .

    In patients with acute ischemic stroke or transient ischemic attack, only RIR can predict recurrent stroke, especially those with large atherosclerosis, and adverse functional outcomes
    .



    Original source:
    Li J, Pan Y, Xu J, et al.


    Residual Inflammatory Risk Predicts Poor Prognosis in Acute Ischemic Stroke or Transient Ischemic Attack Patients.
    Stroke.


    Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.